Key HighlightsThird-quarterRevenuewas USD 110.7 million, up 260% from USD 30.8 million a year earlier, with Spacecraft Solutions at USD 106.0 million against USD 21.4 million and launch revenue down 50% to USD 4.7 million.GAAP net loss narrowed to USD 94.2 million, or USD 0.56 …
Key Highlights0.04 is the consensus EPS estimate per the screener snapshot for both Almonty and Talon Metals, while Inhibrx Biosciences, Inc. (NASDAQ:INBX) carries -2.35, Immix -0.19 and Cosan none, all reporting after the market closes on November 13, 2026.2.71 billion is the USD marketCapitalizationof …
Key HighlightsAEVEX (NYSE:AVEX) shares rose 11.49% in after-hours trading on November 11, 2026, on top of a 4.57% gain in the regular session.Third-quarterRevenuegrew 56.5% to USD 189.7 million, and adjusted EBITDA rose to USD 30.8 million, aMarginof 16.2%.The drone and autonomous systems maker raised …
Key HighlightsNet income was USD 11.7 million, or USD 0.19 per diluted share, against a net loss of USD 39.9 million, or USD 0.76, a year earlier; adjustedNet Incomewas USD 14.2 million, or USD 0.23 per share.Net sales rose 0.4% to USD 271.2 million, …
Key Highlights246.95 billion is the USD marketCapitalizationof Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG) per the screener snapshot, ahead of USD 155.24 billion for Sumitomo Mitsui and USD 122.66 billion for Mizuho, together USD 524.85 billion, calculated.0.34 is the consensus EPS estimate for Mitsubishi UFJ, …
Operating costs and expenses rose to USD 113.5 million from USD 66.3 million, which the company attributed mainly to transaction and stock-based compensation costs tied to the business combination.Research and Developmentwas USD 68.4 million and general and administrative expense was USD 44.6 million.Operating Incomewas …
Key Highlights614.25 is the negative EPS estimate per the screener snapshot for Jaguar Health, Inc. (NASDAQ:JAGX), an extreme figure that is flagged, against -3.84 for Arrive AI, -3.33 for Creative Media, -2.5 for Tevogen and -2.35 for Inhibrx.6.44 million is the USD marketCapitalizationof Jaguar …
On the technical side, Rigetti reported that its 108-qubit Cepheus-1 system reached 99.5% median two-qubit gate fidelity, the accuracy target the company had set. Fidelity matters because errors compound quickly as quantum computers scale, and higher accuracy brings useful applications closer. TheBalance Sheetremains strong: …
The FDA authorized the Investigational New Drug application for a Phase 2 study of rexaceract in June 2026. The company plans to start the study in the first quarter of 2027 at sites in the United States, Australia and Europe, and expects to submit …
Key Highlights1.33 is the consensus EPS estimate per the screener snapshot for GDEV Inc. (NASDAQ:GDEV), flagged for review, against 0.4 for OptimumBank, 0.21 for Kolibri, 0.19 for Flexible Solutions and 0.12 for SBC Medical.538.92 million is the USD marketCapitalizationof SBC Medical Group (NASDAQ:SBC) per …